Hsbc Holdings PLC Amphastar Pharmaceuticals, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 7,284 shares of AMPH stock, worth $285,095. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,284

Previous 6,718 8.43%

Holding current value

$285,095

Previous $268,000 31.72%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.99 - $50.09 $20,936 - $28,350	566 Added 8.43%	7,284 $353,000
Q2 2024 Aug 12, 2024	SELL	$38.65 - $43.48 $27,480 - $30,914	-711 Reduced 9.57%	6,718 $268,000
Q1 2024 May 15, 2024	BUY	$42.85 - $63.45 $318,332 - $471,370	7,429 New	7,429 $326,000
Q3 2023 Nov 13, 2023	BUY	$45.51 - $65.0 $325,988 - $465,595	7,163 New	7,163 $329,000
Q4 2022 Feb 14, 2023	BUY	$27.93 - $31.27 $63,596 - $71,201	2,277 Added 28.14%	10,370 $290,000
Q3 2022 Nov 14, 2022	BUY	$27.56 - $37.75 $13,917 - $19,063	505 Added 6.66%	8,093 $232,000
Q2 2022 Aug 11, 2022	SELL	$29.79 - $42.29 $24,666 - $35,016	-828 Reduced 9.84%	7,588 $263,000
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $193,231 - $306,763	8,416 New	8,416 $308,000
Q4 2021 Feb 11, 2022	SELL	$18.14 - $23.29 $393,964 - $505,812	-21,718 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$17.11 - $20.92 $20,788 - $25,417	-1,215 Reduced 5.3%	21,718 $437,000
Q1 2021 May 14, 2021	SELL	$17.21 - $20.65 $23,749 - $28,496	-1,380 Reduced 5.68%	22,933 $420,000
Q3 2020 Nov 12, 2020	BUY	$17.99 - $22.22 $12,880 - $15,909	716 Added 3.03%	24,313 $460,000
Q2 2020 Aug 14, 2020	BUY	$14.25 - $22.46 $89,276 - $140,711	6,265 Added 36.15%	23,597 $530,000
Q1 2020 May 15, 2020	BUY	$12.66 - $20.08 $62,059 - $98,432	4,902 Added 39.44%	17,332 $255,000
Q4 2019 Feb 14, 2020	SELL	$17.07 - $20.64 $274,707 - $332,159	-16,093 Reduced 56.42%	12,430 $240,000
Q3 2019 Nov 14, 2019	BUY	$19.12 - $22.62 $545,359 - $645,190	28,523 New	28,523 $566,000

Others Institutions Holding AMPH

# of Institutions

286

Shares Held

34.9M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Amphastar Pharmaceuticals, Inc. Transaction History